Manoj Nargund
Dr. Manoj Nargund is a trained Pharmacologist {Doctor of Medicine (MD)} from University of Mumbai, India, & also holds a Diploma in Pharmaceutical Business Management. He has earlier served as Resident Medical Officer in internal medicine & ICU in prestigious public hospitals at Mumbai for 3 years; has been on teaching faculty for Pharmacology for medical & pharmacy graduates, & has 5 publications in peer-reviewed journals. As an Asia Pacific Medical Affairs & Clinical R&D professional in pharmaceutical industry for over 21 years, he has led key products in companies like Pfizer, Johnson & Johnson, Novartis, Zydus Cadila, Macleods, Abbott, & GSK, in multiple therapy areas, including in Respiratory & Infectious Diseases, to address unmet therapeutic needs of patients with asthma, COPD, ILD/IPF, PAH, & in various bacterial & fungal respiratory infections. Some of his key achievements in these areas include, introduction of doxofylline, montelukast & deflazacort for asthma/COPD as per GINA/GOLD guidelines; introduction of 3rd/4th generation beta-lactams & fluoroquinolones; & implementation of various digital/non-digital medical education intiatives for physicians & patients. He is passionate about learning & implementing strategies for addressing the challenges of sub-optimal control of asthma & COPD, & increasing anti-microbial resistance (AMR).